ImStar Therapeutics
Vancouver
About ImStar Therapeutics
ImStar Therapeutics is a biotech company that develops treatments for patients with amyotrophic lateral sclerosis. Its product pipeline is comprised of IMS-088, a small-molecule compound designed to address immune system activation pathway involved in neurodegeneration; and TDP-43 Associated NF-kB Activation Inhibitors.ImStar Therapeutics was founded in 2012 and is based in Vancouver, Canada.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.8M
- Funding stage: Seed
- Last round: Grant (Feb 2017)
- Website: imstartx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Neuroscience, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/imstar-therapeutics-129217 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.